-
1
-
-
0038283046
-
Cancer antigen-125 associated with multiple benign and malignant pathologies
-
Miralles C., Orea M., Espana P., Provencio M., Sanchez A., Cantos B., et al. Cancer antigen-125 associated with multiple benign and malignant pathologies. Ann Surg Oncol 10 (2003) 150-154
-
(2003)
Ann Surg Oncol
, vol.10
, pp. 150-154
-
-
Miralles, C.1
Orea, M.2
Espana, P.3
Provencio, M.4
Sanchez, A.5
Cantos, B.6
-
2
-
-
0037263967
-
Current status of the molecular characterization of the ovarian cancer antigen CA-125 and implications for its use in clinical screening
-
Whitehouse C., and Solomon E. Current status of the molecular characterization of the ovarian cancer antigen CA-125 and implications for its use in clinical screening. Gynecol Oncol 88 (2003) 152-157
-
(2003)
Gynecol Oncol
, vol.88
, pp. 152-157
-
-
Whitehouse, C.1
Solomon, E.2
-
3
-
-
0020559574
-
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer
-
Bast Jr. R.C., Klug T.L., St John E., Jenison E., Niloff J.M., Lazarus H., et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309 (1983) 883-887
-
(1983)
N Engl J Med
, vol.309
, pp. 883-887
-
-
Bast Jr., R.C.1
Klug, T.L.2
St John, E.3
Jenison, E.4
Niloff, J.M.5
Lazarus, H.6
-
4
-
-
0034128498
-
CA-125 production by the peritoneum: in-vitro and in-vivo studies
-
Epiney M., Bertossa C., Weil A., Campana A., and Bischof P. CA-125 production by the peritoneum: in-vitro and in-vivo studies. Hum Reprod 15 (2000) 1261-1265
-
(2000)
Hum Reprod
, vol.15
, pp. 1261-1265
-
-
Epiney, M.1
Bertossa, C.2
Weil, A.3
Campana, A.4
Bischof, P.5
-
5
-
-
0033014416
-
Cancer antigen-125: a sensitive marker of ascites in patients with liver cirrhosis
-
Zuckerman E., Lanir A., Sabo E., Rosenvald-Zuckerman T., Matter I., Yeshurun D., et al. Cancer antigen-125: a sensitive marker of ascites in patients with liver cirrhosis. Am J Gastroenterol 94 (1999) 1613-1618
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 1613-1618
-
-
Zuckerman, E.1
Lanir, A.2
Sabo, E.3
Rosenvald-Zuckerman, T.4
Matter, I.5
Yeshurun, D.6
-
6
-
-
0030245748
-
Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125
-
Zeimet A.G., Marth C., Offner F.A., Obrist P., Uhl-Steidl M., Feichtinger H., et al. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125. Gynecol Oncol 62 (1996) 384-389
-
(1996)
Gynecol Oncol
, vol.62
, pp. 384-389
-
-
Zeimet, A.G.1
Marth, C.2
Offner, F.A.3
Obrist, P.4
Uhl-Steidl, M.5
Feichtinger, H.6
-
7
-
-
3242772892
-
Update on the immunology, diagnosis and management of systemic lupus erythematosus
-
Reeves G.E. Update on the immunology, diagnosis and management of systemic lupus erythematosus. Intern Med J 34 (2004) 338-347
-
(2004)
Intern Med J
, vol.34
, pp. 338-347
-
-
Reeves, G.E.1
-
8
-
-
0025898473
-
Serum levels of CA-125 are elevated in patients with active systemic lupus erythematosus
-
Moncayo R., and Moncayo H. Serum levels of CA-125 are elevated in patients with active systemic lupus erythematosus. Obstet Gynecol 77 (1991) 932-934
-
(1991)
Obstet Gynecol
, vol.77
, pp. 932-934
-
-
Moncayo, R.1
Moncayo, H.2
-
9
-
-
0028798516
-
Elevated serum CA-125 in progressive systemic sclerosis with pleural effusion
-
Kimura K., Ezoe K., Yokozeki H., Katayama I., and Nishioka K. Elevated serum CA-125 in progressive systemic sclerosis with pleural effusion. J Dermatol 22 (1995) 28-31
-
(1995)
J Dermatol
, vol.22
, pp. 28-31
-
-
Kimura, K.1
Ezoe, K.2
Yokozeki, H.3
Katayama, I.4
Nishioka, K.5
-
10
-
-
0029880466
-
False positive pleural biopsy and high CA-125 levels in serum and pleural effusion in systemic lupus erythematosus
-
Yucel A.E., Calguneri M., and Ruacan S. False positive pleural biopsy and high CA-125 levels in serum and pleural effusion in systemic lupus erythematosus. Clin Rheumatol 15 (1996) 197-199
-
(1996)
Clin Rheumatol
, vol.15
, pp. 197-199
-
-
Yucel, A.E.1
Calguneri, M.2
Ruacan, S.3
-
11
-
-
0031858997
-
Lack of correlation between tumor markers (CA-125 and SCC) and systemic lupus erythematosus activity
-
Miret C., Font J., Molina R., Filella X., Vivancos J., Munoz-Rodriguez F.J., et al. Lack of correlation between tumor markers (CA-125 and SCC) and systemic lupus erythematosus activity. Anticancer Res 18 (1998) 1341-1344
-
(1998)
Anticancer Res
, vol.18
, pp. 1341-1344
-
-
Miret, C.1
Font, J.2
Molina, R.3
Filella, X.4
Vivancos, J.5
Munoz-Rodriguez, F.J.6
-
12
-
-
0032953105
-
Morbidity and mortality in systemic lupus erythematosus during a five year period. A multicenter prospective study of 1,000 patients. European working party on systemic lupus erythematosus
-
Cervera R., Khamashta M.A., Font J., Sebastiani G.D., Gil A., Lavilla P., et al. Morbidity and mortality in systemic lupus erythematosus during a five year period. A multicenter prospective study of 1,000 patients. European working party on systemic lupus erythematosus. Medicine (Baltimore) 78 (1999) 167-175
-
(1999)
Medicine (Baltimore)
, vol.78
, pp. 167-175
-
-
Cervera, R.1
Khamashta, M.A.2
Font, J.3
Sebastiani, G.D.4
Gil, A.5
Lavilla, P.6
-
13
-
-
0022408539
-
Ascites in systemic lupus erythematosus
-
Mier A., and Weir W. Ascites in systemic lupus erythematosus. Ann Rheum Dis 44 (1985) 778-779
-
(1985)
Ann Rheum Dis
, vol.44
, pp. 778-779
-
-
Mier, A.1
Weir, W.2
-
14
-
-
0034107775
-
Elevated serum CA-125 levels in patients with nephrotic syndrome-induced ascites
-
Sevinc A., Buyukberber S., Sari R., Turk H.M., and Ates M. Elevated serum CA-125 levels in patients with nephrotic syndrome-induced ascites. Anticancer Res 20 (2000) 1201-1203
-
(2000)
Anticancer Res
, vol.20
, pp. 1201-1203
-
-
Sevinc, A.1
Buyukberber, S.2
Sari, R.3
Turk, H.M.4
Ates, M.5
-
15
-
-
0030838510
-
Plasma protein abnormalities in nephrotic syndrome: effect on plasma colloid osmotic pressure and viscosity
-
Joven J., Cliville X., Camps J., Espinel E., Simo J., Vilella E., et al. Plasma protein abnormalities in nephrotic syndrome: effect on plasma colloid osmotic pressure and viscosity. Clin Chem 43 (1997) 1223-1231
-
(1997)
Clin Chem
, vol.43
, pp. 1223-1231
-
-
Joven, J.1
Cliville, X.2
Camps, J.3
Espinel, E.4
Simo, J.5
Vilella, E.6
-
17
-
-
0036560755
-
The CA-125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure
-
O'Brien T.J., Beard J.B., Underwood L.J., and Shigemasa K. The CA-125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure. Tumour Biol 23 (2002) 154-169
-
(2002)
Tumour Biol
, vol.23
, pp. 154-169
-
-
O'Brien, T.J.1
Beard, J.B.2
Underwood, L.J.3
Shigemasa, K.4
-
18
-
-
0042206865
-
Characterization of the oligosaccharides associated with the human ovarian tumor marker CA-25
-
Kui Wong N., Easton R.L., Panico M., Sutton-Smith M., Morrison J.C., Lattanzio F.A., et al. Characterization of the oligosaccharides associated with the human ovarian tumor marker CA-25. J Biol Chem 278 (2003) 28619-28634
-
(2003)
J Biol Chem
, vol.278
, pp. 28619-28634
-
-
Kui Wong, N.1
Easton, R.L.2
Panico, M.3
Sutton-Smith, M.4
Morrison, J.C.5
Lattanzio, F.A.6
|